Subconjunctival versus Topical Platelet-rich Plasma for Dry Eye: Retrospective Study

NMO journal 2026 Open access

Read full text
Authors: Shikha Agarwal, Snehal Vinay Singh, Anurag Agrawal
DOI: 10.4103/jnmo.jnmo_64_25
Cited by: 1
References: 9

Abstract

Abstract Purpose: Dry eye disease (DED) is a prevalent condition impairing the quality of life, with conventional treatments often failing to address underlying inflammation in moderate-to-severe cases. Platelet-rich plasma (PRP), rich in growth factors, promotes ocular surface healing, but optimal delivery methods remain unclear. This study compares the efficacy and safety of subconjunctival PRP injections versus topical PRP eye drops for moderate-to-severe DED. Methodology: A retrospective cohort study analysed the electronic health records from a tertiary eye care centre in Lucknow, India (August 2019–February 2021). Patients aged 18–65 years with DED (Schirmer’s test

Fields of Study & Subjects

Ocular Surface and Contact Lens Periodontal Regeneration and Treatments Corneal Surgery and Treatments

Publication details

Journal / source
NMO journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
20
Issue
1
Pages
70–74
Publication date
1 January 2026
Language
EN